Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick S Buckner

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Molecular and Biochemical Parasitology|September 17, 2005
Upregulation of sterol C14-demethylase expression in Trypanosoma cruzi treated with sterol biosynthesis inhibitorsEleanor G Hankins, John R Gillespie, Kendra Aikenhead, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2009
Isoquinoline-based analogs of the cancer drug clinical candidate tipifarnib as anti-Trypanosoma cruzi agentsNaveen Kumar Chennamaneni, Jenifer Arif, Frederick S Buckner, et al.
Journal of Medicinal Chemistry|August 19, 2005
The protein farnesyltransferase inhibitor Tipifarnib as a new lead for the development of drugs against Chagas diseaseOliver Hucke, Michael H Gelb, Christophe L M J Verlinde, et al.
Microbes and Infection|September 25, 2002
Leishmania major activates IL-1 alpha expression in macrophages through a MyD88-dependent pathwayThomas R Hawn, Adrian Ozinsky, David M Underhill, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|August 27, 2005
Protein farnesyl transferase inhibitors for the treatment of malaria and African trypanosomiasisFrederick S Buckner, Richard T Eastman, Kohei Yokoyama, et al.
Journal of Lipid Research|December 13, 2005
Thematic review series: lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylationRichard T Eastman, Frederick S Buckner, Kohei Yokoyama, et al.
Indian Journal of Experimental Biology|July 29, 2009
High-throughput screening of amastigotes of Leishmania donovani clinical isolates against drugs using a colorimetric beta-lactamase assaySwati Mandal, Mahendra Maharjan, Sudipto Ganguly, et al.
The Biochemical Journal|July 27, 2002
Trypanosoma brucei prenylated-protein carboxyl methyltransferase prefers farnesylated substratesFrederick S Buckner, David P Kateete, George W Lubega, et al.
Transfusion|September 1, 2005
Leishmania inactivation in human pheresis platelets by a psoralen (amotosalen HCl) and long-wavelength ultraviolet irradiationRichard T Eastman, Lynn K Barrett, Kent Dupuis, et al.
Allergy and Asthma Proceedings|January 1, 2020
A 71-year-old man with recurrent pulmonary mycobacterial avium complex infections and lymphopeniaTaha Al-Shaikhly, Frederick S Buckner, Matthew C Altman, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Molecular and Biochemical Parasitology|September 17, 2005
Upregulation of sterol C14-demethylase expression in Trypanosoma cruzi treated with sterol biosynthesis inhibitorsEleanor G Hankins, John R Gillespie, Kendra Aikenhead, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2009
Isoquinoline-based analogs of the cancer drug clinical candidate tipifarnib as anti-Trypanosoma cruzi agentsNaveen Kumar Chennamaneni, Jenifer Arif, Frederick S Buckner, et al.
Journal of Medicinal Chemistry|August 19, 2005
The protein farnesyltransferase inhibitor Tipifarnib as a new lead for the development of drugs against Chagas diseaseOliver Hucke, Michael H Gelb, Christophe L M J Verlinde, et al.
Microbes and Infection|September 25, 2002
Leishmania major activates IL-1 alpha expression in macrophages through a MyD88-dependent pathwayThomas R Hawn, Adrian Ozinsky, David M Underhill, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|August 27, 2005
Protein farnesyl transferase inhibitors for the treatment of malaria and African trypanosomiasisFrederick S Buckner, Richard T Eastman, Kohei Yokoyama, et al.
Journal of Lipid Research|December 13, 2005
Thematic review series: lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylationRichard T Eastman, Frederick S Buckner, Kohei Yokoyama, et al.
Indian Journal of Experimental Biology|July 29, 2009
High-throughput screening of amastigotes of Leishmania donovani clinical isolates against drugs using a colorimetric beta-lactamase assaySwati Mandal, Mahendra Maharjan, Sudipto Ganguly, et al.
The Biochemical Journal|July 27, 2002
Trypanosoma brucei prenylated-protein carboxyl methyltransferase prefers farnesylated substratesFrederick S Buckner, David P Kateete, George W Lubega, et al.
Transfusion|September 1, 2005
Leishmania inactivation in human pheresis platelets by a psoralen (amotosalen HCl) and long-wavelength ultraviolet irradiationRichard T Eastman, Lynn K Barrett, Kent Dupuis, et al.
Allergy and Asthma Proceedings|January 1, 2020
A 71-year-old man with recurrent pulmonary mycobacterial avium complex infections and lymphopeniaTaha Al-Shaikhly, Frederick S Buckner, Matthew C Altman, et al.
Pageof 12